New rapid laboratory test for congestive heart failure B-type natriuretic peptide (BNP)
Barlow, J.F.
South Dakota Journal of Medicine 55(11): 467
2002
ISSN/ISBN: 0038-3317 PMID: 12449586 Document Number: 542542
Document emailed within 1 workday
Related Documents
Stenner, E.; Buiatti, A.; Barbati, G.; Merlo, M.; Sinagra, G.; Biasioli, B. 2012: Comparative Evaluation of B-Type Natriuretic Peptide and Mid-Regional Pro-A-Type Natriuretic Peptide Changes from Admission to Discharge in Prognosis of Acute Decompensated Heart Failure Patients Clinical Laboratory 58(5-6): 585-589Sirithunyanont, C.; Leowattana, W.; Sukumalchantra, Y.; Chaisupamonkollarp, S.; Watanawaroon, S.; Chivatanaporn, B.; Bhuripanyo, K.; Mahanonda, N. 2003: Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases Journal of the Medical Association of Thailand 86(Suppl 1): S87-S95
O'Connor, J.; Meurer, L.N. 2002: B-type natriuretic peptide is an accurate predictor of heart failure in the emergency department Journal of Family Practice 51(10): 816
Prahash, A.; Lynch, T. 2004: B-type natriuretic peptide: a diagnostic, prognostic, and therapeutic tool in heart failure American Journal of Critical Care: An Official Publication American Association of Critical-Care Nurses 13(1): 46-53; Quiz: 54-55
Wang, S.; Qu, X.; Qu, Y.; Yu, Y.; Feng, W. 2014: The effect of B-type brain natriuretic peptide on patients with acute decompensated heart failure coexisting with lung cancer: a randomized controlled clinical trial Die Pharmazie 69(3): 212-216
Perrella, M.A.; Aarhus, L.L.; Heublein, D.M.; Lewicki, J.A.; Burnett, J.C. 1993: Biologic role of atrial natriuretic factor clearance receptor in congestive heart failure American Journal of Physiology 265(1 Pt 2): H401-H408
Rehman, S.U.; Januzzi, J.L. 2008: Advances in heart failure: natriuretic peptide testing Panminerva Medica 50(2): 139-151
Chen, H.H.; Burnett, J.C. 1998: C-type natriuretic peptide: the endothelial component of the natriuretic peptide system Journal of Cardiovascular Pharmacology 32(Suppl 3): S22-S28
Al-Meslmani, B.M.; Fahoum, S.K.; Shamia, M.G. 2005: N-terminal-probrain natriuretic peptide and echocardiography in patients with systolic heart failure Saudi Medical Journal 26(11): 1695-1698
Indolfi, C.; Piscione, F.; Volpe, M.; Lembo, G.; De Campora, P.; Russolillo, E.; Ambrosini, V.; Condorelli, M.; Chiariello, M. 1991: The effects of atrial natriuretic peptide on left ventricular function in subjects with heart failure Cardiologia 36(5): 351-356
Wang, F.; Li, W.; Huang, J.; Wang, L.; Bian, W-yan.; Pang, H-min.; Wang, Y.; Xu, Z-min.; Li, Y-shi. 2006: Prognostic value of N-terminal-pro-brain natriuretic peptide on admission in patients with chronic heart failure Zhonghua Xin Xue Guan Bing Za Zhi 34(1): 28-32
Rusconi, C.; Faggiano, P.; Ghizzoni, G.; Sorgato, A.; Minzioni, G.; Sabatini, T. 1996: Congestive heart failure due to rapid right ventricular obliteration by metastatic malignant melanoma Minerva Cardioangiologica 44(3): 123-125
Kubinyi, A.; Bacior, Bła.; Szot, W.; Klecha, A.; Kawecka-Jaszcz, K. 2003: Cardiopulmonary exercise test and heart rate variability in patients with congestive heart failure who underwent physical rehabilitation Przeglad Lekarski 60(11): 732-736
Angelika Hammerer-Lercher; Puschendorf, B.; Mair, J. 2001: Cardiac Natriuretic Peptides: New Laboratory Parameters In Heart Failure Patients Clinical Laboratory 47(5-6): 265-277
Mazovets, O.L.; Trifonov, I.R.; Katrukha, A.G.; Gratsianskiĭ, N.A. 2009: Admission and predischarge levels of NT pre brain natriuretic peptide in patients hospitalized because of worsening heart failure. relation to risk of death in the next 6-12 months Kardiologiia 49(1): 34-38
Boffa, G.Maria.; Zaninotto, M.; Bacchiega, E.; Nalli, C.; Forni, M.; Tiso, E.; Cacciavillani, L.; Razzolini, R.; Plebani, M. 2005: Correlations between clinical presentation, brain natriuretic peptide, big endothelin-1, tumor necrosis factor-alpha and cardiac troponins in heart failure patients Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 6(2): 125-132
Król, W.; Jawień, A. 1981: Congestive heart failure in infants and children with atrial septal defects of the ostium secundum type Pediatria Polska 56(10): 1219-1226
1997: Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group Lancet 349(9049): 375-380
Francis, G.S.; Pierpont, G.L. 1988: Pathophysiology of congestive heart failure secondary to congestive and ischemic cardiomyopathy Cardiovascular Clinics 19(1): 57-74
Gomberg-Maitland, M.; Baran, D.A.; Fuster, V. 2001: Treatment of congestive heart failure: guidelines for the primary care physician and the heart failure specialist Archives of Internal Medicine 161(3): 342-352